MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ERNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ernexa Therapeutics (ERNA) Ownership - Who owns Ernexa Therapeutics?

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 617 798-6700
Employees
7
Web
https://www.ernexatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.9M
P/E Ratio
0.00
Total Cash
9.18M
Projected Growth
N/A
Total Debt
389K
Revenue
N/A
Risk (Beta)
2.96
Dividend Yield
N/A
Total Cash/Share
7.87
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ERNA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ERNA
A.I. Advisor
published General Information

General Information

a developer of biomedical research products in the field of stem cells and regenerative medicine

Industry Biotechnology

Profile
Details
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 617 798-6700
Employees
7
Web
https://www.ernexatx.com